Molecular design and delivery of siRNA
暂无分享,去创建一个
[1] K. Taira,et al. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. , 2003, Nucleic acids research.
[2] A. Ellington,et al. Crystal structures of a series of RNA aptamers complexed to the same protein target , 1998, Nature Structural Biology.
[3] S. Kawakami,et al. In Vivo Gene Delivery to the Liver Using Novel Galactosylated Cationic Liposomes , 2000, Pharmaceutical Research.
[4] G. P. Smith,et al. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.
[5] O. Uhlenbeck,et al. A thermodynamic analysis of the sequence-specific binding of RNA by bacteriophage MS2 coat protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[6] Additional RNA-protein interactions facilitate in vitro selection by ribosome display , 2005 .
[7] J. M. Thomson,et al. Argonaute2 Is the Catalytic Engine of Mammalian RNAi , 2004, Science.
[8] A. Ellington,et al. Crystal structure of an RNA aptamer–protein complex at 2.8 Å resolution , 1998, Nature Structural Biology.
[9] Ernst Wagner,et al. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. , 2003, Bioconjugate chemistry.
[10] P. Rowley,et al. Inhibition of telomerase activity in human cancer cells by RNA interference. , 2003, Molecular cancer therapeutics.
[11] J. Murray,et al. The three-dimensional structures of two complexes between recombinant MS2 capsids and RNA operator fragments reveal sequence-specific protein-RNA interactions. , 1997, Journal of molecular biology.
[12] T. Irimura,et al. Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer , 2004, Clinical Cancer Research.
[13] S. Asano,et al. Maxizymes and small hairpin-type RNAs that are driven by a tRNA promoter specifically cleave a chimeric gene associated with leukemia in vitro and in vivo. , 2003, Cancer research.
[14] J. Lisziewicz,et al. Gene Therapy Approaches to HIV Infection , 2002, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.
[15] T. Du,et al. Asymmetry in the Assembly of the RNAi Enzyme Complex , 2003, Cell.
[16] A. Pasquinelli,et al. A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA , 2001, Science.
[17] Matthias John,et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.
[18] Inder M Verma,et al. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] B. Li,et al. Expression profiling reveals off-target gene regulation by RNAi , 2003, Nature Biotechnology.
[20] Ali Ehsani,et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells , 2002, Nature Biotechnology.
[21] Simple and rapid synthesis of siRNA derived from in vitro transcribed shRNA. , 2003, Nucleic acids research. Supplement.
[22] S. Hammond,et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells , 2000, Nature.
[23] G. Hannon,et al. Crystal Structure of Argonaute and Its Implications for RISC Slicer Activity , 2004, Science.
[24] G. Hannon,et al. Germline transmission of RNAi in mice , 2003, Nature Structural Biology.
[25] A. Fire,et al. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] A. Pasquinelli,et al. Genes and Mechanisms Related to RNA Interference Regulate Expression of the Small Temporal RNAs that Control C. elegans Developmental Timing , 2001, Cell.
[27] S. Kawakami,et al. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. , 2004, Biochemical and biophysical research communications.
[28] W. Marasco,et al. Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells , 2001, Cancer Gene Therapy.
[29] Patrick J. Paddison,et al. Stable suppression of gene expression by RNAi in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[30] Judy Lieberman,et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors , 2005, Nature Biotechnology.
[31] Ki-Young Lee,et al. Cloned zebrafish by nuclear transfer from long-term-cultured cells , 2002, Nature Biotechnology.
[32] R. Bernards,et al. Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.
[33] S. Jayasena,et al. Functional siRNAs and miRNAs Exhibit Strand Bias , 2003, Cell.
[34] K. Taira,et al. Strategies for generation of an siRNA expression library directed against the human genome. , 2003, Oligonucleotides.
[35] K. Taira,et al. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs. , 2002, Antisense & nucleic acid drug development.
[36] Leaf Huang,et al. Antibody-directed liposomes as drug-delivery vehicles , 1989 .
[37] D. Engelke,et al. Effective expression of small interfering RNA in human cells , 2002, Nature Biotechnology.
[38] A. Plückthun,et al. In vitro selection and evolution of functional proteins by using ribosome display. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[39] Judy Lieberman,et al. RNA interference targeting Fas protects mice from fulminant hepatitis , 2003, Nature Medicine.
[40] K. Taira,et al. U6 promoter–driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells , 2002, Nature Biotechnology.
[41] Tyra G. Wolfsberg,et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Rana,et al. siRNA function in RNAi: a chemical modification analysis. , 2003, RNA.
[43] A. Caudy,et al. Role for a bidentate ribonuclease in the initiation step of RNA interference , 2001 .
[44] Thomas Tuschl,et al. RISC is a 5' phosphomonoester-producing RNA endonuclease. , 2004, Genes & development.
[45] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[46] M. Banan,et al. The ins and outs of RNAi in mammalian cells. , 2004, Current pharmaceutical biotechnology.
[47] E. Nabel,et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[48] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[49] P. Wils,et al. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors , 2002, Gene Therapy.